Stay updated on Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.15.0 to v2.15.2, and the date has changed from April 22, 2025, to April 25, 2025.
    Difference
    0.7%
    Check dated 2025-05-01T05:26:55.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The webpage has updated its date from March 24, 2025, to April 22, 2025.
    Difference
    0.7%
    Check dated 2025-04-23T22:18:47.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.15.0, replacing the previous version 2.14.4.
    Difference
    1.0%
    Check dated 2025-04-16T14:43:03.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 24, 2025.
    Difference
    0.7%
    Check dated 2025-04-09T09:49:49.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The date has been updated from January 30, 2025, to March 24, 2025.
    Difference
    0.7%
    Check dated 2025-03-25T14:11:10.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T21:15:35.000Z thumbnail image

Stay in the know with updates to Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.